Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 603050 | ISIN: US9871841089 | Ticker-Symbol: YWA
Tradegate
21.01.25
11:37 Uhr
30,600 Euro
+0,200
+0,66 %
Branche
Versorger
Aktienmarkt
Sonstige
1-Jahres-Chart
YORK WATER COMPANY Chart 1 Jahr
5-Tage-Chart
YORK WATER COMPANY 5-Tage-Chart
RealtimeGeldBriefZeit
30,00030,20021.01.
29,60030,80021.01.
GlobeNewswire (Europe)
102 Leser
Artikel bewerten:
(0)

The York Water Company: York Water Company Reports 3rd Quarter and Nine Months Earnings

Finanznachrichten News

YORK, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- The York Water Company's (NASDAQ:YORW) President, JT Hand, announced the Company's financial results for the third quarter and the first nine months of 2024.

President Hand reported that third quarter operating revenues of $19,715,000 increased $948,000, but net income of $5,863,000 decreased $1,705,000 compared to the third quarter of 2023. Basic and Diluted Earnings per share of $0.41 for the three-month period decreased $0.12 compared to the same period last year. Increased revenues were primarily due to revenues from Distribution System Improvement charge (DSIC) and growth in the customer base. The DSIC is a Pennsylvania Public Utility Commission allowed charge that water utilities collect from customers for the replacement of aging infrastructure. The increased revenue was more than offset by higher operation and maintenance expenses, depreciation, and a lower allowance for funds used during construction (AFUDC). AFUDC is the cost of debt and equity funds used to finance plant construction. Income taxes increased due to lower deductions from the IRS tangible property regulations.

President Hand also reported that the first nine months operating revenues of $56,093,000 increased $3,158,000, but net income of $15,183,000 decreased $2,562,000 compared to the first nine months of 2023. Increased revenues were primarily due to an increase in rates effective March 1, 2023, revenues from DSIC, and growth in the customer base. The Company incurred lower pension costs. The increased revenue and lower pension costs were more than offset by higher operation and maintenance expenses, depreciation, interest on debt, and a lower AFUDC. Basic and Diluted Earnings per share of $1.06 for the nine-month period decreased $0.18 compared to the same period last year.

During the first nine months of 2024, the Company invested $33 million in capital projects for armoring and replacing the spillway of the Lake Williams dam, wastewater treatment plant construction, as well as various replacements and improvements to infrastructure and routine items. In addition, the Company invested $264,000 in the acquisition of water and wastewater systems, including the Houston Run Community Water System. This is the Company's second acquisition in Lancaster County and the Company now serves in 57 municipalities within four counties in south-central Pennsylvania. The Company estimates it will invest an additional $9.7 million in 2024, excluding acquisitions, for completion of armoring and replacing the spillway of the Lake Williams dam and additional main extensions, and routine improvements to its pipes, service lines, and other facilities to ensure a safe, adequate, and reliable supply of drinking water and to maintain proper handling and disposal of wastewater for the Company's growing customer base.

Period Ended September 30
In 000's (except per share)
QuarterNine Months
2024 2023 2024 2023
Operating Revenues$19,715$18,767$56,093$52,935
Net Income$5,863$7,568$15,183$17,745
Average Number of Common Shares Outstanding 14,354 14,301 14,340 14,289
Basic and Diluted Earnings Per Common Share$0.41$0.53$1.06$1.24
Dividends Declared Per Common Share$0.2108$0.2027$0.6324$0.6081

This news release may contain forward-looking statements regarding the Company's operational and financial expectations. These statements are based on currently available information and are subject to risks, uncertainties, and other events which could cause the Company's actual results to be materially different from the results described in this statement. The Company undertakes no duty to update any forward-looking statement.


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.